|
TTC27 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.564200E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.438300E-02 |
| Normal-vs-Stage2 |
1.253960E-01 |
| Normal-vs-Stage3 |
3.883600E-02 |
| Normal-vs-Stage4 |
7.990000E-02 |
| Stage1-vs-Stage2 |
8.505200E-01 |
| Stage1-vs-Stage3 |
2.217800E-01 |
| Stage1-vs-Stage4 |
1.467040E-01 |
| Stage2-vs-Stage3 |
3.539000E-01 |
| Stage2-vs-Stage4 |
2.526000E-01 |
| Stage3-vs-Stage4 |
7.978000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.419900E-03 |
| Normal-vs-AfricanAmerican |
2.436800E-01 |
| Normal-vs-Asian |
1.511170E-01 |
| Caucasian-vs-AfricanAmerican |
2.393800E-01 |
| Caucasian-vs-Asian |
2.160600E-01 |
| AfricanAmerican-vs-Asian |
1.100830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.276010E-01 |
| Normal-vs-Female |
1.59395999999035E-05 |
| Male-vs-Female |
1.357990E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.953380E-01 |
| Normal-vs-Extreme_Weight |
6.459500E-02 |
| Normal-vs-Obese |
6.302600E-03 |
| Normal-vs-Extreme_Obese |
8.151200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.793000E-01 |
| Normal_Weight-vs-Obese |
1.552760E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.539600E-01 |
| Extreme_Weight-vs-Obese |
1.906440E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.766200E-01 |
| Obese-vs-Extreme_Obese |
1.450620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.422600E-03 |
| Normal-vs-Age(41-60Yrs) |
2.657100E-03 |
| Normal-vs-Age(61-80Yrs) |
1.544770E-01 |
| Normal-vs-Age(81-100Yrs) |
7.059600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.141000E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.802100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.268480E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.308100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.877400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.715000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.165850E-02 |
| Normal-VS-Type2 PRCC |
5.896800E-01 |
| Normal-VS-KIRP CIMP |
4.203400E-03 |
| Normal-VS-Unclassified PRCC |
3.842100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.204590E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.087970E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.812000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.64158999998998E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
7.445600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.237400E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.743400E-01 |
| Normal-vs-N1 |
9.775700E-03 |
| Normal-vs-N2 |
4.917400E-03 |
| N0-vs-N1 |
1.584500E-02 |
| N0-vs-N2 |
3.108500E-02 |
| N1-vs-N2 |
9.616400E-01 |
|
|
